Identifying Breast Cancer Patients at High Risk for Bone Metastases
Marco Colleoni(European Institute of Oncology), Monica Castiglione‐Gertsch, Andrea Veronesi(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Edda Simoncini(International Breast Cancer Study Group), Richard D. Gelber(Harvard University), Jurij Lindtner(International Breast Cancer Study Group), Carl‐Magnus Rudenstam(International Breast Cancer Study Group), Beat Thürlimann(Kantonsspital St. Gallen), John Forbes, John P. Collins(International Breast Cancer Study Group), Alan S. Coates(Breast Cancer Trials), A. Gudgeon(International Breast Cancer Study Group), Karen N. Price(International Breast Cancer Study Group), Hans-Jörg Senn, Martin F. Fey(European Union), F. Cavalli(International Breast Cancer Study Group), Aron Goldhirsch(European Institute of Oncology), H. Cortés-Funes(Centre Hospitalier René-Dubos), Marco Bonetti(International Breast Cancer Study Group), Anne O’Neill(International Breast Cancer Study Group)
Cited by 125
Related Papers
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
|Journal of Clinical Oncology|2000|3.8k
Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
|New England Journal of Medicine|1994|3.7k
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
|Annals of Oncology|2013|3.7k